143 related articles for article (PubMed ID: 35641267)
21. Genotype-Phenotype Correlations in Neurofibromatosis Type 1: Identification of Novel and Recurrent
Napolitano F; Dell'Aquila M; Terracciano C; Franzese G; Gentile MT; Piluso G; Santoro C; Colavito D; Patanè A; De Blasiis P; Sampaolo S; Paladino S; Melone MAB
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885913
[TBL] [Abstract][Full Text] [Related]
22. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.
Sabbagh A; Pasmant E; Imbard A; Luscan A; Soares M; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanné-Chantelot C; Vidaud D; Parfait B; Wolkenstein P
Hum Mutat; 2013 Nov; 34(11):1510-8. PubMed ID: 23913538
[TBL] [Abstract][Full Text] [Related]
23. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.
Eisenbarth I; Beyer K; Krone W; Assum G
Am J Hum Genet; 2000 Feb; 66(2):393-401. PubMed ID: 10677298
[TBL] [Abstract][Full Text] [Related]
24. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
25. NF1 Somatic Mutation in Dystrophic Scoliosis.
Margraf RL; VanSant-Webb C; Mao R; Viskochil DH; Carey J; Hanson H; D'Astous J; Grossmann A; Stevenson DA
J Mol Neurosci; 2019 May; 68(1):11-18. PubMed ID: 30778836
[TBL] [Abstract][Full Text] [Related]
26. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
Yap YS; Munusamy P; Lim C; Chan CHT; Prawira A; Loke SY; Lim SH; Ong KW; Yong WS; Ng SBH; Tan IBH; Callen DF; Lim JCT; Thike AA; Tan PH; Lee ASG
Breast Cancer Res Treat; 2018 Oct; 171(3):719-735. PubMed ID: 29926297
[TBL] [Abstract][Full Text] [Related]
28. Recurrent NF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1).
Buske A; Gewies A; Lehmann R; Rüther K; Algermissen B; Nürnberg P; Tinschert S
Am J Med Genet; 1999 Oct; 86(4):328-30. PubMed ID: 10494088
[TBL] [Abstract][Full Text] [Related]
29. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
Legius E; Brems H
Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
[TBL] [Abstract][Full Text] [Related]
30. Concomitant variants in NF1, LZTR1 and GNAZ genes probably contribute to the aggressiveness of plexiform neurofibroma and warrant treatment with MEK inhibitor.
Cohen-Barak E; Toledano-Alhadef H; Danial-Farran N; Livneh I; Mwassi B; Hriesh M; Zagairy F; Gafni-Amsalem C; Bashir H; Khayat M; Warrour N; Sher O; Marom D; Postovsky S; Dujovny T; Ziv M; Shalev SA
Exp Dermatol; 2022 May; 31(5):775-780. PubMed ID: 34913528
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform Neurofibromatosis type 1.
Chai P; Luo Y; Zhou C; Wang Y; Fan X; Jia R
BMC Med Genet; 2019 Sep; 20(1):158. PubMed ID: 31533651
[TBL] [Abstract][Full Text] [Related]
32. Giant Cell Lesions of the Jaws Involving RASopathy Syndromes.
Luna M; Wolsefer N; Zambrano CX; Stojanov IJ
Acta Stomatol Croat; 2022 Mar; 56(1):77-88. PubMed ID: 35382488
[TBL] [Abstract][Full Text] [Related]
33. Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1.
N Abdel-Aziz N; Y El-Kamah G; A Khairat R; R Mohamed H; Z Gad Y; El-Ghor AM; Amr KS
Mol Genet Genomic Med; 2021 Dec; 9(12):e1631. PubMed ID: 34080803
[TBL] [Abstract][Full Text] [Related]
34. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene.
Colman SD; Williams CA; Wallace MR
Nat Genet; 1995 Sep; 11(1):90-2. PubMed ID: 7550323
[TBL] [Abstract][Full Text] [Related]
35. Congenital Retroperitoneal Teratoma in Neurofibromatosis Type 1.
Yap P; Super L; Qin J; Burgess T; Prodanovic Z; Edwards C; Thomas R; Carpenter K; Tan TY
Pediatr Blood Cancer; 2016 Apr; 63(4):706-8. PubMed ID: 26514327
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
37. A search for evidence of somatic mutations in the NF1 gene.
John AM; Ruggieri M; Ferner R; Upadhyaya M
J Med Genet; 2000 Jan; 37(1):44-9. PubMed ID: 10633134
[TBL] [Abstract][Full Text] [Related]
38. How to Distinguish Solitary Neurofibroma From Neurofibromatosis Type 1.
Guo C; Zhou L; Sun Y; Hu X
J Craniofac Surg; 2022 May; 33(3):889-891. PubMed ID: 35727670
[TBL] [Abstract][Full Text] [Related]
39. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
[TBL] [Abstract][Full Text] [Related]
40. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
Pinson S; Wolkenstein P
Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]